180 related articles for article (PubMed ID: 12091294)
21. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
22. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Marr BL; Mettelman BB; Bode MM; Gross SJ
J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
[TBL] [Abstract][Full Text] [Related]
23. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
Seth R; Gray PH; Tudehope DI
Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
[TBL] [Abstract][Full Text] [Related]
24. The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease.
Shrivastava A; Lyon A; McIntosh N
Eur J Pediatr; 2000 May; 159(5):380-4. PubMed ID: 10834526
[TBL] [Abstract][Full Text] [Related]
25. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
[TBL] [Abstract][Full Text] [Related]
26. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
[TBL] [Abstract][Full Text] [Related]
27. Early treatment of premature infants with steroids: neurological sequelae.
Prescrire Int; 2007 Jun; 16(89):108-9. PubMed ID: 17582929
[TBL] [Abstract][Full Text] [Related]
28. Early dexamethasone therapy in preterm infants: a follow-up study.
Yeh TF; Lin YJ; Huang CC; Chen YJ; Lin CH; Lin HC; Hsieh WS; Lien YJ
Pediatrics; 1998 May; 101(5):E7. PubMed ID: 9565440
[TBL] [Abstract][Full Text] [Related]
29. Effects of short-term dexamethasone treatment on collagen synthesis and degradation markers in preterm infants with developing lung disease.
Saarela T; Risteli J; Koivisto M
Acta Paediatr; 2003 May; 92(5):588-94. PubMed ID: 12839290
[TBL] [Abstract][Full Text] [Related]
30. High incidence of nephrocalcinosis in extremely preterm infants treated with dexamethasone.
Cranefield DJ; Odd DE; Harding JE; Teele RL
Pediatr Radiol; 2004 Feb; 34(2):138-42. PubMed ID: 14624322
[TBL] [Abstract][Full Text] [Related]
31. Growth effects of systemic versus inhaled steroids in chronic lung disease.
Nicholl RM; Greenough A; King M; Cheeseman P; Gamsu HR
Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F59-61. PubMed ID: 12091295
[TBL] [Abstract][Full Text] [Related]
32. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
Bloomfield FH; Knight DB; Harding JE
J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
[TBL] [Abstract][Full Text] [Related]
33. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
Gross SJ; Anbar RD; Mettelman BB
Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
[TBL] [Abstract][Full Text] [Related]
34. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
Mieskonen S; Eronen M; Malmberg LP; Turpeinen M; Kari MA; Hallman M
Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
[TBL] [Abstract][Full Text] [Related]
35. Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed.
Tarnow-Mordi W; Mitra A
BMJ; 1999 Nov; 319(7222):1385-6. PubMed ID: 10574836
[No Abstract] [Full Text] [Related]
36. Follow-up of preterm infants treated with dexamethasone for chronic lung disease.
O'Shea TM; Kothadia JM; Klinepeter KL; Goldstein DJ; Jackson B; Dillard RG
Am J Dis Child; 1993 Jun; 147(6):658-61. PubMed ID: 8506835
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
[TBL] [Abstract][Full Text] [Related]
38. Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.
Onland W; van Kaam AH; De Jaegere AP; Offringa M
Pediatrics; 2010 Oct; 126(4):e954-64. PubMed ID: 20837588
[TBL] [Abstract][Full Text] [Related]
39. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
40. Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses.
Yates HL; Newell SJ
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F299-303. PubMed ID: 21427126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
